DAR. I agree my view is often " what can go wrong here " So I'll write a " what can go right here " post
What can go right is that Kaiser / AMRN decide to run MITIGATE long enough to get the Exploratory CV endpoints listed..... to confirm the USA R-IT results at say the 2 yr mark
Apparently only poster Laurent and I think this trial is important but IMHO ...a Kaiser run and controlled Outcome trial with CV data that confirms USA R-IT numbers ( or close to it ) to any extent ...would be HUGE.
Market Data 
Markets 
AI
